• (+)-Bicuculline: Technical Guide for GABAA Antagonist Workfl

  2026-08-04

  (+)-Bicuculline is a classical GABAA receptor antagonist essential for research on inhibitory neurotransmission and synaptic NMDA receptor modulation. This compound addresses the need for precise dissection of GABAergic signaling in neuroscience applications but is unsuitable for diagnostic or therapeutic use.

• Chloroquine Diphosphate: Autophagy, Ferroptosis, and Next-Ge

  2026-08-04

  Explore how Chloroquine diphosphate enables advanced autophagy and ferroptosis modulation for cancer research. This article offers a deep dive into mechanistic insights and practical assay optimization, standing apart from standard protocol guides.

• Mitoxantrone and ABCG2: Overcoming Resistance in Translation

  2026-08-03

  This thought-leadership article explores the mechanistic and strategic opportunities for translational researchers using Mitoxantrone, a proven topoisomerase II inhibitor. By integrating recent advances on ABCG2-mediated drug resistance and the disruptive impact of marein as a chemosensitizer, it provides actionable guidance for designing next-generation combination protocols in cancer research, with a focus on B-CLL and multidrug-resistant models.

• Cabazitaxel (XRP6258): Technical Workflow for Resistant Mode

  2026-08-03

  Cabazitaxel addresses the challenge of chemoresistance in cancer research, specifically targeting P-glycoprotein-expressing and taxane-resistant cell lines. It is intended for use in DMSO or ethanol-based protocols and should not be applied in aqueous systems or for long-term solution storage.

• Metronidazole (SKU B1976): Reliable Solutions for Lab Assays

  2026-08-02

  This article delivers scenario-driven, evidence-based guidance for biomedical researchers using Metronidazole (SKU B1976) in cell viability, proliferation, and transporter inhibition assays. Leveraging its dual function as a nitroimidazole antibiotic and OAT3 inhibitor, the discussion highlights how B1976's high purity and validated properties address critical lab challenges, ensuring reproducibility and data integrity.

• IMPDH Inhibition Suppresses PEDV Replication via Host Metabo

  2026-08-01

  The referenced study uncovers how porcine epidemic diarrhea virus (PEDV) reprograms host nucleotide metabolism, specifically targeting inosine monophosphate dehydrogenase (IMPDH), to enable its replication. Both genetic and pharmacological inhibition of IMPDH, including with Merimepodib (VX-497), markedly reduced PEDV proliferation, highlighting a promising host-directed antiviral strategy.

• (-)-Arctigenin as a MEK1 Inhibitor: Applied Workflows & Insi

  2026-07-31

  (-)-Arctigenin (APExBIO, N2399) stands out as a dual MEK1 and iNOS inhibitor, uniquely positioned for dissecting NF-κB-driven cancer progression and neuroprotection workflows. This article translates recent breast cancer findings into actionable protocols, troubleshooting tips, and advanced use-cases, maximizing the experimental impact of this high-purity, research-grade compound.

• Arachidonic Acid in Immune Research: Protocols and Innovatio

  2026-07-31

  Arachidonic Acid, a polyunsaturated omega-6 fatty acid, is transforming immune research by enabling rapid, reproducible insights into eicosanoid biosynthesis and humoral immunity. This guide delivers actionable protocols, troubleshooting strategies, and key advances—empowering laboratories to optimize inflammatory and immunological assays with confidence.

• Resiquimod (R-848) in Hydrogel-Enhanced Cancer Immunotherapy

  2026-07-30

  Resiquimod (R-848) revolutionizes tumor ablation by coupling potent innate immune activation with programmable hydrogel-based delivery, overcoming both safety and efficacy barriers. This guide translates cutting-edge research into actionable workflows and troubleshooting tips for maximizing translational impact in cancer immunotherapy.

• Verbascoside as a PKC/NF-κB Inhibitor: Unraveling Bone Signa

  2026-07-30

  Explore how Verbascoside, a potent PKC/NF-κB inhibitor, enables precision studies in osteoclastogenesis by dissecting signaling specificity and integrating new insights from translational bone research. This article delivers a uniquely practical perspective for designing advanced PKC/NF-κB-mediated signaling assays.

• SB525334 in TGF-beta1 Pathway Modulation: Beyond Fibrosis Mo

  2026-07-29

  Explore how SB525334, a potent TGF-beta1 receptor inhibitor, uniquely empowers advanced research into TGF-beta signaling and disease modeling. This in-depth guide reveals how SB525334 bridges molecular mechanisms and translational assay design.

• Partial β-Secretase Inhibition Preserves Synaptic Function i

  2026-07-29

  Satir et al. (2020) demonstrate that partial inhibition of β-secretase can significantly reduce amyloid β production without impairing synaptic transmission in neuronal cultures. This finding clarifies the therapeutic window for β-secretase inhibition in Alzheimer's research and informs experimental design for neurodegeneration studies.

• Epigenetic Drivers of Metastatic Identity in HNSCC: WDR54’s

  2026-07-28

  A recent study provides a multi-omic portrait of metastatic head and neck squamous cell carcinoma (HNSCC), revealing WDR54 as a central epigenetic regulator of cellular identity reshaping during metastasis. These findings illuminate mechanisms of tumor plasticity and suggest new avenues for biomarker and therapeutic development.

• Advancing Translational Assays: Benzyl-activated Streptavidi

  2026-07-28

  Explore how Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) empower translational researchers to achieve sensitive, reproducible detection of early cell death and streamline biotinylated molecule capture. We bridge mechanistic insight from cardiomyocyte I/R injury studies with strategic guidance for advanced immunoprecipitation, protein interaction, and drug screening workflows, offering differentiated expertise for modern biomedical labs.

• SB-505124 Hydrochloride: Applied Workflows in TGF-β Pathway

  2026-07-27

  SB-505124 hydrochloride empowers researchers to dissect TGF-β/activin signaling with high specificity and reproducibility, enabling advanced studies in fibrosis, cancer, and cellular mechanotransduction. Its robust solubility in DMSO and non-cytotoxic profile streamline complex assay setups and translational protocols.

16410 records 1/1094 page Next 12345 下5页 Last page